XML 50 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2023
shares
Dec. 31, 2023
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
During the quarter ended December 31, 2023, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions, or written plans for the purchase or sale of our securities set forth in the table below:
Name and PositionDateAction
Rule 10b5-1(1)
Expiration DateTotal Shares of Common Stock to be Sold
Martha Morrell,
Chief Medical Officer
September 5, 2023AdoptionXSeptember 3, 2024
91,667 (2)
_________________
1.Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
2.Including the exercise and sale of up to 80,662 shares of the Company’s common stock subject to stock options.
Rule 10b5-1 Arrangement Adopted false  
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Martha Morrell [Member]    
Trading Arrangements, by Individual    
Name Martha Morrell  
Title Chief Medical Officer  
Adoption Date September 5, 2023  
Arrangement Duration 305 days  
Aggregate Available 91,667 91,667
Martha Morrell Arrangement - Subject to Stock Options [Member] | Martha Morrell [Member]    
Trading Arrangements, by Individual    
Aggregate Available 80,662 80,662